Elmas Nazli Gonc
Overview
Explore the profile of Elmas Nazli Gonc including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ozkocer C, Visal Okur F, Demirbilek H, Altintas B, Cetin N, Kuskonmaz B, et al.
Turk J Haematol
. 2024 Nov;
42(1):15-24.
PMID: 39513346
Objective: This study was planned to evaluate long-term post-transplant complications in patients who underwent transplantation with the diagnosis of Fanconi anemia (FA) in childhood in our bone marrow transplantation unit...
2.
Sogukpinar M, Urel Demir G, Utine G, Gonc E, Ozon Z, Simsek-Kiper P
Eur J Pediatr
. 2024 Jul;
183(9):3831.
PMID: 39023646
No abstract available.
3.
Sogukpinar M, Urel Demir G, Utine G, Gonc E, Ozon Z, Simsek-Kiper P
Eur J Pediatr
. 2024 Jun;
183(9):3819-3829.
PMID: 38879704
Achondroplasia (ACH; MIM #100,800), caused by a heterozygous gain of function pathogenic variant in the fibroblast growth factor receptor 3 gene (FGFR3; MIM*134,934), is the most prevalent and most readily...
4.
Unsal Y, Baltu D, Gulhan B, Visal Okur F, Ozaltin F, Duzova A, et al.
Pediatr Transplant
. 2024 May;
28(4):e14778.
PMID: 38767038
Introduction: Calcineurin inhibitors (CNIs) are widely used in transplantation. Although CNI-related hyperkalemia is common (10%-60.6%), the underlying pathogenetic mechanism is not well-elucidated and may lead to dose adjustment or treatment...
5.
Riedmeier M, Antonini S, Brandalise S, Costa T, Daiggi C, de Figueiredo B, et al.
Eur J Endocrinol
. 2024 Mar;
190(4):G15-G24.
PMID: 38552173
Objective: Mitotane is an important cornerstone in the treatment of pediatric adrenal cortical tumors (pACC), but experience with the drug in the pediatric age group is still limited and current...
6.
Celik N, Unsal Y, Emet D, Mete Yesil A, Sencan B, Gonc E, et al.
Turk Arch Pediatr
. 2022 Sep;
57(6):621-629.
PMID: 36168668
Objective: This study aimed to investigate the psychosocial impact of the pandemic in pediatric patients with congenital adrenal hyperplasia and their families and whether congenital adrenal hyperplasia imposes an additional...
7.
Gonc E, Kandemir N
Curr Opin Endocrinol Diabetes Obes
. 2021 Nov;
29(1):78-83.
PMID: 34839325
Purpose Of Review: In this review, we have summarized the current data on the effect of sexual precocity and treatment with gonadotropin-releasing hormone analogues (GnRHa) on body composition. Recent Findings:...
8.
Alikasifoglu A, Unsal Y, Gonc E, Ozon Z, Kandemir N, Alikasifoglu M
J Pediatr Endocrinol Metab
. 2021 Sep;
34(12):1573-1584.
PMID: 34525271
Objectives: Hereditary hypophosphatemic rickets (HR) is conventionally treated with phosphate and calcitriol. Exploring genotype and phenotypic spectrum of X-linked hypophosphatemic rickets (XLHR), focusing on short-term, long-term, and pubertal impact of...
9.
Alikasifoglu A, Celik N, Ozon Z, Gonc E, Kandemir N
Pituitary
. 2021 Sep;
25(1):167-179.
PMID: 34518999
Purpose: Prevalence, presentation and clinical outcome of prolactinomas vary in children and adults. In this study, we evaluated the clinical features and outcome of children and adolescents with prolactinoma to...
10.
Vuralli D, Ozon Z, Gonc E, Alikasifoglu A, Kandemir N
J Pediatr Endocrinol Metab
. 2019 Dec;
33(1):99-105.
PMID: 31804960
Introduction Studies evaluating effects of gonadotropin-releasing hormone agonist (GnRHa) on weight and body-mass-index (BMI) in girls with idiopathic central precocious puberty (iCPP) include short-term effects. The aim of this study...